Evaluation of the dual mTOR/PI3K inhibitors Gedatolisib (PF-05212384) and PF-04691502 against ovarian cancer xenograft models

Langdon, SP; Kay, C; Um, IH; Dodds, M; Muir, M; Sellar, G; Kan, J; Gourley, C; Harrison, DJ

Langdon, SP (reprint author), Univ Edinburgh, Inst Genet & Mol Med, Canc Res UK Edinburgh Ctr & Edinburgh Pathol, Edinburgh EH4 2XU, Midlothian, Scotland.

SCIENTIFIC REPORTS, 2019; 9 ():